Company intelligence / Profile preview
Nanolipo
Florianópolis, Santa Catarina, Brazil
- Ownership
- Private
- Development stage
- Other
01
Overview
NanoLipo is a Brazilian biotechnology company specializing in the development of advanced lipid-based nanotechnology for drug delivery and aesthetic applications. The company utilizes proprietary nanocarriers to enhance the stability, penetration, and efficacy of active ingredients in dermatological and cosmetic formulations. Their platform focuses on liposomal systems that can be customized for various therapeutic needs, including hair loss and skin rejuvenation. NanoLipo aims to bridge the gap between nanotechnology research and market-ready healthcare solutions.
- Therapeutic areas
- DermatologyMetabolic Disorders
- Modalities
- Lipid nanoparticle delivery therapyNanoparticle
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Nanolipo.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Nanolipo.